课题基金 / 基金详情

Design and Simulation of Valvular Replacement Biomaterials

Design and Simulation of Valvular Replacement Biomaterials
瓣膜置换生物材料的设计与模拟
批准号:
8461138
负责人:
JOSEPH H GORMAN
金额:
$55.22万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-20 至 2016-02-29

项目摘要

项目成果

JOSEPH H GORMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary: For the foreseeable future, bioprosthetic heart valves (BHV) fabricated from xenograft biomaterials will remain the dominant replacement prosthetic valve design. However, BHV durability remains limited to 10-15 years. Failure is usually the result of leaflet tructural deterioration mediated by fatigue and/or tissue mineralization. Thus, independent of valve design specifics (e.g. standard stented valve, percutaneous delivery), the development of novel xenograft biomaterials with improved durability remains an important clinical goal. This represents a unique cardiovascular engineering challenge resulting from the extreme valvular mechanical demands that occur with blood contact. Yet, current BHV assessment relies exclusively on device-level evaluations, which are confounded by simultaneous and highly coupled biomaterial mechanical behaviors and fatigue, valve design, hemodynamics, and calcification. Thus, despite decades of clinical BHV usage and growing popularity, there exists no acceptable method for assessing and simulating BHV durability at the component biomaterial level. This situation has contributed to the current stagnation in BHV biomaterial development, limiting rationally developed improvements in BHV durability. We hypothesize that a biomechanically rigorous and physiologically realistic in-vivo approach can be developed for a mechanistic understanding of intrinsic BHV biomaterial performance. Once developed, such an approach can be used to rationally design novel biomaterials that significantly improve BHV durability. While calcification prevention has not been completely solved, ethanol post-treatment has been shown to strongly reduce its onset. Moreover, others and we have shown that tissue degeneration is a major independent mechanism underlying BHV limited durability both in-vitro and in-vivo. Thus, our focus will be on mechanisms of early tissue degeneration and means to reduce damage accumulation, leading to improving BHV durability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Catheter Based Cardiovascular Device Retrieval System
  • 批准号:
    10268993
  • 项目类别:
  • 资助金额:
    $170.83万
  • 财政年份:
    2018
  • 负责人:
    JOSEPH H GORMAN
  • 依托单位:
Catheter Based Cardiovascular Device Retrieval System
  • 批准号:
    9558779
  • 项目类别:
  • 资助金额:
    $21.38万
  • 财政年份:
    2018
  • 负责人:
    JOSEPH H GORMAN
  • 依托单位:
Catheter Based Cardiovascular Device Retrieval System
  • 批准号:
    10010592
  • 项目类别:
  • 资助金额:
    $127.03万
  • 财政年份:
    2018
  • 负责人:
    JOSEPH H GORMAN
  • 依托单位:
Quantitative Force Measurements to Optimize Valve Repair for Ischemic MR
  • 批准号:
    8824961
  • 项目类别:
  • 资助金额:
    $71.5万
  • 财政年份:
    2013
  • 负责人:
    JOSEPH H GORMAN
  • 依托单位:
海外基金